Skip to main content
Top
Published in: Calcified Tissue International 6/2018

01-12-2018 | Original Research

Early Fracture Healing is Delayed in the Col1a2+/G610C Osteogenesis Imperfecta Murine Model

Authors: Roberta Besio, Silvia Maruelli, Severine Battaglia, Laura Leoni, Simona Villani, Pierre Layrolle, Antonio Rossi, Valerie Trichet, Antonella Forlino

Published in: Calcified Tissue International | Issue 6/2018

Login to get access

Abstract

Osteogenesis imperfecta (OI) is a rare heritable skeletal dysplasia mainly caused by type I collagen abnormalities and characterized by bone fragility and susceptibility to fracture. Over 85% of the patients carry dominant mutations in the genes encoding for the collagen type I α1 and α2 chains. Failure of bone union and/or presence of hyperplastic callus formation after fracture were described in OI patients. Here we used the Col1a2+/G610C mouse, carrying in heterozygosis the α2(I)-G610C substitution, to investigate the healing process of an OI bone. Tibiae of 2-month-old Col1a2+/G610C and wild-type littermates were fractured and the healing process was followed at 2, 3, and 5 weeks after injury from fibrous cartilaginous tissue formation to its bone replacement by radiography, micro-computed tomography (µCT), histological and biochemical approaches. In presence of similar fracture types, in Col1a2+/G610C mice an impairment in the early phase of bone repair was detected compared to wild-type littermates. Smaller callus area, callus bone surface, and bone volume associated to higher percentage of cartilage and lower percentage of bone were evident in Col1a2+/G610C at 2 weeks post fracture (wpf) and no change by 3 wpf. Furthermore, the biochemical analysis of collagen extracted from callus 2 wpf revealed in mutants an increased amount of type II collagen, typical of cartilage, with respect to type I, characteristic of bone. This is the first report of a delay in OI bone fracture repair at the modeling phase.
Appendix
Available only for authorised users
Literature
1.
go back to reference Forlino A, Marini JC (2016) Osteogenesis imperfecta. Lancet 387:1657–1671CrossRef Forlino A, Marini JC (2016) Osteogenesis imperfecta. Lancet 387:1657–1671CrossRef
2.
go back to reference Marini JC, Forlino A, Bachinger HP, Bishop NJ, Byers PH, Paepe A, Fassier F, Fratzl-Zelman N, Kozloff KM, Krakow D et al (2017) Osteogenesis imperfecta. Nat Rev Dis Primers 3:17052CrossRef Marini JC, Forlino A, Bachinger HP, Bishop NJ, Byers PH, Paepe A, Fassier F, Fratzl-Zelman N, Kozloff KM, Krakow D et al (2017) Osteogenesis imperfecta. Nat Rev Dis Primers 3:17052CrossRef
3.
go back to reference Mehlman CT, Shepherd MA, Norris CS, McCourt JB (2012) Diagnosis and treatment of osteopenic fractures in children. Curr Osteoporos Rep 10:317–321CrossRef Mehlman CT, Shepherd MA, Norris CS, McCourt JB (2012) Diagnosis and treatment of osteopenic fractures in children. Curr Osteoporos Rep 10:317–321CrossRef
4.
go back to reference Besio R, Forlino A (2015) Treatment options for osteogenesis imperfecta. Expert Opin Orphan D 3:165–181CrossRef Besio R, Forlino A (2015) Treatment options for osteogenesis imperfecta. Expert Opin Orphan D 3:165–181CrossRef
5.
go back to reference Morgan EF, De Giacomo A, Gerstenfeld LC (2014) Overview of skeletal repair (fracture healing and its assessment). Methods Mol Biol 1130:13–31CrossRef Morgan EF, De Giacomo A, Gerstenfeld LC (2014) Overview of skeletal repair (fracture healing and its assessment). Methods Mol Biol 1130:13–31CrossRef
6.
go back to reference Marsell R, Einhorn TA (2011) The biology of fracture healing. Injury 42:551–555CrossRef Marsell R, Einhorn TA (2011) The biology of fracture healing. Injury 42:551–555CrossRef
7.
go back to reference Morshed S (2014) Current options for determining fracture union. Adv Med 2014:708574CrossRef Morshed S (2014) Current options for determining fracture union. Adv Med 2014:708574CrossRef
8.
go back to reference Rauch F, Travers R, Parfitt AM, Glorieux FH (2000) Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. Bone 26:581–589CrossRef Rauch F, Travers R, Parfitt AM, Glorieux FH (2000) Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. Bone 26:581–589CrossRef
9.
go back to reference Uveges TE, Collin-Osdoby P, Cabral WA, Ledgard F, Goldberg L, Bergwitz C, Forlino A, Osdoby P, Gronowicz GA, Marini JC (2008) Cellular mechanism of decreased bone in Brtl mouse model of OI: imbalance of decreased osteoblast function and increased osteoclasts and their precursors. J Bone Miner Res 23:1983–1994CrossRef Uveges TE, Collin-Osdoby P, Cabral WA, Ledgard F, Goldberg L, Bergwitz C, Forlino A, Osdoby P, Gronowicz GA, Marini JC (2008) Cellular mechanism of decreased bone in Brtl mouse model of OI: imbalance of decreased osteoblast function and increased osteoclasts and their precursors. J Bone Miner Res 23:1983–1994CrossRef
10.
go back to reference Li H, Jiang X, Delaney J, Franceschetti T, Bilic-Curcic I, Kalinovsky J, Lorenzo JA, Grcevic D, Rowe DW, Kalajzic I (2010) Immature osteoblast lineage cells increase osteoclastogenesis in osteogenesis imperfecta murine. Am J Pathol 176:2405–2413CrossRef Li H, Jiang X, Delaney J, Franceschetti T, Bilic-Curcic I, Kalinovsky J, Lorenzo JA, Grcevic D, Rowe DW, Kalajzic I (2010) Immature osteoblast lineage cells increase osteoclastogenesis in osteogenesis imperfecta murine. Am J Pathol 176:2405–2413CrossRef
11.
go back to reference Gamble JG, Rinsky LA, Strudwick J, Bleck EE (1988) Non-union of fractures in children who have osteogenesis imperfecta. J Bone Joint Surg 70:439–443CrossRef Gamble JG, Rinsky LA, Strudwick J, Bleck EE (1988) Non-union of fractures in children who have osteogenesis imperfecta. J Bone Joint Surg 70:439–443CrossRef
12.
go back to reference Agarwal V, Joseph B (2005) Non-union in osteogenesis imperfecta. J Pediatr Orthop B 14:451–455CrossRef Agarwal V, Joseph B (2005) Non-union in osteogenesis imperfecta. J Pediatr Orthop B 14:451–455CrossRef
13.
go back to reference Hsiao MS, Mormino MA, Esposito PW, Burke BA (2013) Distal humerus atrophic nonunion in a child with osteogenesis imperfecta. J Pediatr Orthop 33:725–729CrossRef Hsiao MS, Mormino MA, Esposito PW, Burke BA (2013) Distal humerus atrophic nonunion in a child with osteogenesis imperfecta. J Pediatr Orthop 33:725–729CrossRef
14.
go back to reference Cheung MS, Glorieux FH, Rauch F (2007) Natural history of hyperplastic callus formation in osteogenesis imperfecta type V. J Bone Miner Res 22:1181–1186CrossRef Cheung MS, Glorieux FH, Rauch F (2007) Natural history of hyperplastic callus formation in osteogenesis imperfecta type V. J Bone Miner Res 22:1181–1186CrossRef
15.
go back to reference Brenner RE, Vetter U, Nerlich A, Worsdorfer O, Teller WM, Muller PK (1989) Biochemical analysis of callus tissue in osteogenesis imperfecta type IV. Evidence for transient overmodification in collagen types I and III. J Clin Invest 84:915–921CrossRef Brenner RE, Vetter U, Nerlich A, Worsdorfer O, Teller WM, Muller PK (1989) Biochemical analysis of callus tissue in osteogenesis imperfecta type IV. Evidence for transient overmodification in collagen types I and III. J Clin Invest 84:915–921CrossRef
16.
go back to reference Ramirez N, Vilella FE, Colon M, Flynn JM (2003) Osteogenesis imperfecta and hyperplastic callus formation in a family: a report of three cases and a review of the literature. J Pediatr Orthop B 12:88–96CrossRef Ramirez N, Vilella FE, Colon M, Flynn JM (2003) Osteogenesis imperfecta and hyperplastic callus formation in a family: a report of three cases and a review of the literature. J Pediatr Orthop B 12:88–96CrossRef
17.
go back to reference Cheung MS, Azouz EM, Glorieux FH, Rauch F (2008) Hyperplastic callus formation in osteogenesis imperfecta type V: follow-up of three generations over ten years. Skeletal Radiol 37:465–467CrossRef Cheung MS, Azouz EM, Glorieux FH, Rauch F (2008) Hyperplastic callus formation in osteogenesis imperfecta type V: follow-up of three generations over ten years. Skeletal Radiol 37:465–467CrossRef
18.
go back to reference Munns CF, Rauch F, Zeitlin L, Fassier F, Glorieux FH (2004) Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate. J Bone Miner Res 19:1779–1786CrossRef Munns CF, Rauch F, Zeitlin L, Fassier F, Glorieux FH (2004) Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate. J Bone Miner Res 19:1779–1786CrossRef
19.
go back to reference Dwan K, Phillipi CA, Steiner RD, Basel D (2016) Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database Syst Rev 10:CD005088PubMed Dwan K, Phillipi CA, Steiner RD, Basel D (2016) Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database Syst Rev 10:CD005088PubMed
20.
go back to reference Franzone JM, Finkelstein MS, Rogers KJ, Kruse RW (2017) Evaluation of fracture and osteotomy union in the setting of osteogenesis imperfecta: Reliability of the modified radiographic union score for tibial fractures (RUST). J Pediatr Orthop. (in press) Franzone JM, Finkelstein MS, Rogers KJ, Kruse RW (2017) Evaluation of fracture and osteotomy union in the setting of osteogenesis imperfecta: Reliability of the modified radiographic union score for tibial fractures (RUST). J Pediatr Orthop. (in press)
21.
go back to reference Delos D, Yang X, Ricciardi BF, Myers ER, Bostrom MP, Camacho NP (2008) The effects of RANKL inhibition on fracture healing and bone strength in a mouse model of osteogenesis imperfecta. Journal of Orthop Res 26:153–164CrossRef Delos D, Yang X, Ricciardi BF, Myers ER, Bostrom MP, Camacho NP (2008) The effects of RANKL inhibition on fracture healing and bone strength in a mouse model of osteogenesis imperfecta. Journal of Orthop Res 26:153–164CrossRef
22.
go back to reference Meganck JA, Begun DL, McElderry JD, Swick A, Kozloff KM, Goldstein SA, Morris MD, Marini JC, Caird MS (2013) Fracture healing with alendronate treatment in the Brtl/+ mouse model of osteogenesis imperfecta. Bone 56:204–212CrossRef Meganck JA, Begun DL, McElderry JD, Swick A, Kozloff KM, Goldstein SA, Morris MD, Marini JC, Caird MS (2013) Fracture healing with alendronate treatment in the Brtl/+ mouse model of osteogenesis imperfecta. Bone 56:204–212CrossRef
23.
go back to reference Enderli T, Burtch S, Templet J, Carriero A (2016) Animal models of osteogenesis imperfecta: applications in clinical research. Orthop Res Rev 8:41–55CrossRef Enderli T, Burtch S, Templet J, Carriero A (2016) Animal models of osteogenesis imperfecta: applications in clinical research. Orthop Res Rev 8:41–55CrossRef
24.
go back to reference Daley E, Streeten EA, Sorkin JD, Kuznetsova N, Shapses SA, Carleton SM, Shuldiner AR, Marini JC, Phillips CL, Goldstein SA et al (2010) Variable bone fragility associated with an Amish COL1A2 variant and a knock-in mouse model. J Bone Miner Res 25:247–261CrossRef Daley E, Streeten EA, Sorkin JD, Kuznetsova N, Shapses SA, Carleton SM, Shuldiner AR, Marini JC, Phillips CL, Goldstein SA et al (2010) Variable bone fragility associated with an Amish COL1A2 variant and a knock-in mouse model. J Bone Miner Res 25:247–261CrossRef
25.
go back to reference Marsh JL, Slongo TF, Agel J, Broderick JS, Creevey W, DeCoster TA, Prokuski L, Sirkin MS, Ziran B, Henley B et al (2007) Fracture and dislocation classification compendium—2007: Orthopaedic Trauma Association classification, database and outcomes committee. J Orthop Trauma 21:S1–S133CrossRef Marsh JL, Slongo TF, Agel J, Broderick JS, Creevey W, DeCoster TA, Prokuski L, Sirkin MS, Ziran B, Henley B et al (2007) Fracture and dislocation classification compendium—2007: Orthopaedic Trauma Association classification, database and outcomes committee. J Orthop Trauma 21:S1–S133CrossRef
26.
go back to reference Nowalk JR, Flick LM (2008) Visualization of different tissues involved in endochondral ossification with alcian blue hematoxylin and orange G/eosin counterstain. J Histotechnol 31:19–21CrossRef Nowalk JR, Flick LM (2008) Visualization of different tissues involved in endochondral ossification with alcian blue hematoxylin and orange G/eosin counterstain. J Histotechnol 31:19–21CrossRef
27.
go back to reference Stephano JL, Gould M, Rojas-Galicia L (1986) Advantages of picrate fixation for staining polypeptides in polyacrylamide gels. Anal Biochem 152:308–313CrossRef Stephano JL, Gould M, Rojas-Galicia L (1986) Advantages of picrate fixation for staining polypeptides in polyacrylamide gels. Anal Biochem 152:308–313CrossRef
28.
go back to reference Ford JL, Robinson DE, Scammell BE (2004) Endochondral ossification in fracture callus during long bone repair: the localisation of ‘cavity-lining cells’ within the cartilage. J Orthop Res 22:368–375CrossRef Ford JL, Robinson DE, Scammell BE (2004) Endochondral ossification in fracture callus during long bone repair: the localisation of ‘cavity-lining cells’ within the cartilage. J Orthop Res 22:368–375CrossRef
29.
go back to reference Miller EJ, Rhodes RK (1982) Preparation and characterization of the different types of collagen. Methods Enzymol 82 Pt A:33–64CrossRef Miller EJ, Rhodes RK (1982) Preparation and characterization of the different types of collagen. Methods Enzymol 82 Pt A:33–64CrossRef
30.
go back to reference Kulmala KA, Korhonen RK, Julkunen P, Jurvelin JS, Quinn TM, Kroger H, Toyras J (2010) Diffusion coefficients of articular cartilage for different CT and MRI contrast agents. Med Eng Phys 32:878–882CrossRef Kulmala KA, Korhonen RK, Julkunen P, Jurvelin JS, Quinn TM, Kroger H, Toyras J (2010) Diffusion coefficients of articular cartilage for different CT and MRI contrast agents. Med Eng Phys 32:878–882CrossRef
31.
go back to reference Ferguson C, Alpern E, Miclau T, Helms JA (1999) Does adult fracture repair recapitulate embryonic skeletal formation? Mech Dev 87:57–66CrossRef Ferguson C, Alpern E, Miclau T, Helms JA (1999) Does adult fracture repair recapitulate embryonic skeletal formation? Mech Dev 87:57–66CrossRef
32.
go back to reference Bargman R, Posham R, Boskey AL, DiCarlo E, Raggio C, Pleshko N (2012) Comparable outcomes in fracture reduction and bone properties with RANKL inhibition and alendronate treatment in a mouse model of osteogenesis imperfecta. Osteoporos Int 23:1141–1150CrossRef Bargman R, Posham R, Boskey AL, DiCarlo E, Raggio C, Pleshko N (2012) Comparable outcomes in fracture reduction and bone properties with RANKL inhibition and alendronate treatment in a mouse model of osteogenesis imperfecta. Osteoporos Int 23:1141–1150CrossRef
33.
go back to reference Sillence DO, Senn A, Danks DM (1979) Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 16:101–116CrossRef Sillence DO, Senn A, Danks DM (1979) Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 16:101–116CrossRef
34.
go back to reference Masci M, Wang M, Imbert L, Barnes AM, Spevak L, Lukashova L, Huang Y, Ma Y, Marini JC, Jacobsen CM et al (2016) Bone mineral properties in growing Col1a2(+/G610C) mice, an animal model of osteogenesis imperfecta. Bone 87:120–129CrossRef Masci M, Wang M, Imbert L, Barnes AM, Spevak L, Lukashova L, Huang Y, Ma Y, Marini JC, Jacobsen CM et al (2016) Bone mineral properties in growing Col1a2(+/G610C) mice, an animal model of osteogenesis imperfecta. Bone 87:120–129CrossRef
35.
go back to reference Pountos I, Panteli M, Lampropoulos A, Jones E, Calori GM, Giannoudis PV (2016) The role of peptides in bone healing and regeneration: a systematic review. BMC Med 14:103CrossRef Pountos I, Panteli M, Lampropoulos A, Jones E, Calori GM, Giannoudis PV (2016) The role of peptides in bone healing and regeneration: a systematic review. BMC Med 14:103CrossRef
36.
go back to reference Zhang M, Ho HC, Sheu TJ, Breyer MD, Flick LM, Jonason JH, Awad HA, Schwarz EM, O’Keefe RJ (2011) EP1(-/-) mice have enhanced osteoblast differentiation and accelerated fracture repair. J Bone Miner Res 26:792–802CrossRef Zhang M, Ho HC, Sheu TJ, Breyer MD, Flick LM, Jonason JH, Awad HA, Schwarz EM, O’Keefe RJ (2011) EP1(-/-) mice have enhanced osteoblast differentiation and accelerated fracture repair. J Bone Miner Res 26:792–802CrossRef
37.
go back to reference Mirigian LS, Makareeva E, Mertz EL, Omari S, Roberts-Pilgrim AM, Oestreich AK, Phillips CL, Leikin S (2016) Osteoblast malfunction caused by cell stress response to procollagen misfolding in alpha2(I)-G610C mouse model of osteogenesis imperfecta. J Bone Miner Res 31:1608–1616CrossRef Mirigian LS, Makareeva E, Mertz EL, Omari S, Roberts-Pilgrim AM, Oestreich AK, Phillips CL, Leikin S (2016) Osteoblast malfunction caused by cell stress response to procollagen misfolding in alpha2(I)-G610C mouse model of osteogenesis imperfecta. J Bone Miner Res 31:1608–1616CrossRef
38.
go back to reference Gioia R, Panaroni C, Besio R, Palladini G, Merlini G, Giansanti V, Scovassi IA, Villani S, Villa I, Villa A et al (2012) Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy. Stem Cells 30:1465–1476CrossRef Gioia R, Panaroni C, Besio R, Palladini G, Merlini G, Giansanti V, Scovassi IA, Villani S, Villa I, Villa A et al (2012) Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy. Stem Cells 30:1465–1476CrossRef
39.
go back to reference Jepsen KJ, Pennington DE, Lee YL, Warman M, Nadeau J (2001) Bone brittleness varies with genetic background in A/J and C57BL/6J inbred mice. J Bone Miner Res 16:1854–1862CrossRef Jepsen KJ, Pennington DE, Lee YL, Warman M, Nadeau J (2001) Bone brittleness varies with genetic background in A/J and C57BL/6J inbred mice. J Bone Miner Res 16:1854–1862CrossRef
40.
go back to reference Manigrasso MB, O’Connor JP (2008) Comparison of fracture healing among different inbred mouse strains. Calcif Tissue Int 82:465–474CrossRef Manigrasso MB, O’Connor JP (2008) Comparison of fracture healing among different inbred mouse strains. Calcif Tissue Int 82:465–474CrossRef
41.
go back to reference Ji H, Li J, Shao J, He D, Liu Y, Fei W, Luo E (2017) Histopathologic comparison of condylar hyperplasia and condylar osteochondroma by using different staining methods. Oral Surg Oral Med Oral Pathol Oral Radiol 123:320–329CrossRef Ji H, Li J, Shao J, He D, Liu Y, Fei W, Luo E (2017) Histopathologic comparison of condylar hyperplasia and condylar osteochondroma by using different staining methods. Oral Surg Oral Med Oral Pathol Oral Radiol 123:320–329CrossRef
Metadata
Title
Early Fracture Healing is Delayed in the Col1a2+/G610C Osteogenesis Imperfecta Murine Model
Authors
Roberta Besio
Silvia Maruelli
Severine Battaglia
Laura Leoni
Simona Villani
Pierre Layrolle
Antonio Rossi
Valerie Trichet
Antonella Forlino
Publication date
01-12-2018
Publisher
Springer US
Published in
Calcified Tissue International / Issue 6/2018
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-018-0461-x

Other articles of this Issue 6/2018

Calcified Tissue International 6/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.